Articles |
From the Division of Cardiovascular Research (H.A.S., G.S., R.C.S., V.A., J.I., K.W.), St. Elizabeth's Medical Center and Tufts University School of Medicine, Boston, Mass; the Cardiac Unit (H.A.S.), Massachusetts General Hospital, Boston; the Department of Anatomy (G.E.L.), University of Wisconsin Medical School, Madison; and the Department of Cardiovascular Research (S.S.), Berlex Biosciences, Richmond, Calif.
Correspondence to Kenneth Walsh, PhD, Division of Cardiovascular Research, St. Elizabeth's Medical Center, 736 Cambridge St, Boston, MA 02135. E-mail kwalsh{at}OPAL.TUFTS.EDU
| Abstract |
|---|
|
|
|---|
Key Words: homeobox gene Gax cardiac muscle smooth muscle skeletal muscle
| Introduction |
|---|
|
|
|---|
During development, homeobox transcription factors control cell lineage commitment and differentiation by regulating genes necessary for the mature phenotype. Cardiac, smooth, and skeletal muscles are mesodermal derivatives, but each arises from a different location in the mouse embryo. Cardiac muscle, the first muscle lineage to differentiate and become functional, is derived from lateral plate mesoderm. Between 7.5 and 8.0 days pc, two cardiac primordia fuse at the midline to form a simple contractile tube. Among the transcription factors that may regulate this process are Nkx-2.5/Csx, a homeobox-containing gene,6 7 8 GATA-4,9 MEF2C,10 MEF2B,11 dHAND, and eHAND.12 Similarly, most smooth muscle cells are derived from lateral plate mesoderm, but some vascular smooth muscle cells arise from the neural crest.13 14 15 Little is known about transcriptional regulators that are essential for smooth muscle differentiation. MEF2/RSRF family members are expressed in smooth muscle,16 17 as is gax.1 2 Furthermore, a functional MEF2 site occurs in the gax promoter.18 Skeletal muscle cells of the trunk and limbs arise from the somites, but some head muscles arise from regions rostral to the first somite, such as the prechordal plate.19 Skeletal muscle determination and differentiation are regulated by the MyoD family of bHLH transcription factors20 and by the MEF2 family of nuclear factors.10 11
Gax expression has been detected in adult cardiovascular tissues, but its embryonic pattern of expression has not been thoroughly described. Therefore, as a first step toward understanding the role of Gax during embryogenesis, we performed a detailed analysis of its spatial and temporal pattern of expression between 7.5 and 17.5 days pc using immunohistochemistry and in situ hybridization. In addition to its neuroectodermal expression, we report a mesodermal expression pattern that includes the early myocytes of the cardiac, skeletal, and smooth muscle lineages.
| Materials and Methods |
|---|
|
|
|---|
-Gax 8.1) (amino acids SDHSSEHAHL) and N-terminal
(
-Gax 2.1) (amino acids LRSPHATAQGLH) regions of the rat Gax
protein. Specific reactivity was determined in comparison with that of
the rabbit prebleeds. Antibodies were then purified over ImmunoPure
protein A columns (Pierce). Further characterization of these
antibodies was performed by immunohistochemistry using transiently
transfected A10 cells and Western blot analysis of C3H10T1/2
fibroblasts.18
Preparation of Embryos
Embryos were obtained by the natural matings of
C57B1/6JxC57B1/6J mice (Jackson Laboratories, Bar Harbor, Me) as
previously described.21 The day of vaginal plug detection
was designated as day 0.5 pc. Mice were euthanized by cervical
dislocation, and embryos from 7.5 to 17.5 days pc were removed. Embryos
12.5 days pc and older were anesthetized with ethyl ether. Embryos were
then fixed in methyl Carnoy's fixative for immunocytochemistry or 4%
paraformaldehyde for in situ hybridization. Embryos were dehydrated
through graded alcohols and paraffin-embedded. Eight-micron sections
were analyzed.
Western Blot Analysis
Whole-cell protein extracts from embryonic cardiomyocytes at
various ages were a generous gift of Dr Loren Field (Krannert
Institute, Indianapolis, Ind). Thirty micrograms of protein per time
point was separated on a 7.5% polyacrylamide gel under denaturing
conditions and electroblotted on nitrocellulose membranes. The membrane
was blocked with 5% nonfat dry milk in TBS-T and then probed with 4 to
7 µg/mL of the
-Gax 2.1 and
-Gax 8.1 antibodies for 30 minutes
at room temperature. After incubation with primary antibody, the blot
was washed three times in TBS-T, followed by incubation for 20 minutes
with 1:4000 of goat anti-rabbit horseradish peroxidase antibody
(Amersham) in 5% milk/TBS-T at room temperature. The blot was again
washed in PBS, and antigen-antibody complexes were visualized after
incubation for 1 minute with an enhanced luminescence reagent
(Amersham) at room temperature, followed by exposure to Kodak XAR-5
film.
Immunohistochemistry
Immunohistochemistry was performed according to a modified
version of the method of Schatteman et al.22 Fifteen
complete embryos were serially sectioned for immunohistochemical
analysis. In addition, individual sections from one to three embryos
were assessed at several time points, including at least two embryos
for each day between 12.5 and 15.5 days pc. Briefly, embryonic sections
were deparaffinized through xylenes, rehydrated through graded
ethanols, and then rinsed in 0.1 mol/L sodium phosphate buffer, pH 7.5
(PBS). All incubations were performed at room temperature unless
otherwise indicated. Sections were next blocked for 1 hour with 4%
goat serum (GIBCO-BRL) in PBS and then quenched in 0.3% hydrogen
peroxide in PBS for 30 minutes. Sections were incubated with
-Gax
8.1,
-Gax 2.1 (1:3000 in 4% goat serum in PBS), or preimmune serum
control (1:3000 in 4% goat serum in PBS) for 1 hour and then at 4°C
overnight. After a washing in PBS, sections were incubated for 30
minutes with a biotinylated goat anti-rabbit IgG (1:200 dilution in 4%
goat serum in PBS; Vector Laboratories Inc). After the sections were
washed in several changes of PBS, streptavidin/horseradish peroxidase
(1:800, Vector Laboratories Inc) was added and incubated for 1 hour.
This was followed by repeated washes in PBS and a single wash in 0.1
mol/L Tris, pH 7.6. 3,3'-Diaminobenzidine (Sigma) was used as the
chromagen, and then the slides were counterstained with hematoxylin.
Some sections were also analyzed without counterstain. Control sections
incubated with preimmune serum or with secondary antibody alone were
also analyzed. Peptide competition was performed by preincubating
-Gax 8.1 antibody with a 100 times mass excess of its immunogenic
peptide (SDHSSEHAHL) for 90 minutes before immunohistochemistry.
In Situ Hybridization
In situ hybridization was performed according to Lyons et
al23 using [35S]UTP-labeled RNA probes
prepared from a 195-bp segment that spanned both the coding (154-bp)
and 3' untranslated (41-bp) regions of the rat gax gene
(nucleotides 953 to 1148) that had been subcloned into the pBluescript
SK- transcription vector (Stratagene Inc). In situ
localization was confirmed using two other probes from nucleotides 197
to 382 and 455 to 685 (data not shown). All probes excluded both the
homeobox region and CAX repeat. Antisense and sense probes were
transcribed using T3 and T7 RNA polymerases (Promega). The probe for
MyoD mRNA corresponds to the 3' terminal 1000 nucleotides as described
in Sassoon et al.24 Probes were hydrolyzed to an average
size of 150 bases, and ethanol was precipitated before scintillation
counting of a 1-mL sample.
Tissue sections were deparaffinized through xylenes, dehydrated through
graded alcohols, washed in PBS, and then fixed in 4% paraformaldehyde
for 20 minutes. After an additional wash and digestion for 7.5 minutes
with 20 µg/mL proteinase K (Boehringer-Mannheim) at room temperature,
sections were fixed in 4% paraformaldehyde for 5 minutes and then
treated with freshly prepared 0.1 mol/L triethanolamine containing
0.25% acetic anhydride. 35S-labeled RNA probe (50 000
cpm/µL) in hybridization buffer (50% formamide, 10%
dextran sulfate, 1x Denhardt's solution, 0.4 mol/L SSPE, 1
mmol/L EDTA, 50 mmol/L dithiothreitol, and 1 mg/mL tRNA) was added
to each slide. Except for Fig 7G
(with hybridizations performed at
45°C), all hybridizations were performed in a humidified chamber at
50°C for
16 hours. Slides were washed with 5x SSC with 10
mmol/L dithiothreitol at 50°C for 30 minutes and 50% formamide in
4x SSC for 20 minutes at 65°C before treatment with a 20 µg/mL
RNase A solution (Boehringer-Mannheim). They were then passed
through high-stringency washes of 2x SSC for 10 minutes at 37°C and
0.1x SSC for 10 minutes at 37°C before dehydration with ethanol and
air drying. Slides were then dipped in photographic emulsion (NTB-2,
Kodak), dried, and then exposed in the dark for 1 to 2 weeks. These
were then developed (D-19 developer and fixer, Kodak) at 16°C
(according to the manufacturer's instructions) and counterstained with
toluidine blue. Results were analyzed using bright-field and dark-field
optics of a Zeiss Axiophot microscope.
|
| Results |
|---|
|
|
|---|
-Gax 8.1 and
-Gax 2.1 antibodies revealed
nuclear staining in a subset of A10 cells (
5%) that were
transiently transfected with the pCGN-Gax expression vector (Fig 1B
-Gax 8.1 or
-Gax 2.1
antibodies, detected a single band corresponding to the recombinant
fusion protein in C3H10T1/2 fibroblasts transfected with pCGN-Gax (Fig 1C
-HA) of the Gax fusion protein also detected a single band
of identical electrophoretic mobility for cells transfected with
pCGN-Gax. Further evidence of antibody specificity was provided by the
abrogation of Western blot signal with preincubation of the anti-Gax
antibodies with the corresponding immunogenic peptides (data not
shown). Unless otherwise indicated, the immunohistochemical analyses
depicted below were performed with the
-Gax 8.1 antibody because of
its superior signal-to-background stain in tissue sections. However,
comparisons of
100 sections from various developmental time points
revealed similar patterns of Gax distribution with either antibody.
Embryonic sections incubated with preimmune serum or with secondary
antibody alone showed no staining, and the signal was abrogated by
competition with a 100-fold mass excess of immunogenic peptide in all
regions except the renal distal tubule (data not shown).
|
Expression of Gax in Mesodermal Derivatives
Gax protein expression was noted in derivatives of the lateral
plate (cardiomyocytes, visceral and vascular smooth muscle, and stroma
of the lung and kidney) and somitic (skeletal muscles of the trunk and
limbs) mesoderm. Muscles and connective tissue of the head and neck
also prominently expressed Gax protein. No expression of Gax was
detected in the notochord, intermediate mesoderm, or the portion of the
lateral plate mesoderm from which the adrenal cortex, hematopoietic
system, and lymphatic system are derived (data not shown).
Expression of Gax in Lateral Plate Mesoderm Derivatives
Heart. By days 7.5 to 8.0 pc (presomite stage), Gax
protein was noted in the lateral plate mesoderm but was absent in cells
surrounding the intraembryonic coelomic cavity, which becomes the
pericardial cavity (data not shown). Gax protein was noted in the early
heart tube (days 8 to 8.5 pc) (Fig 2A
) and rudimentary
segmented heart, becoming prominent in the bulbus cordis, primitive
ventricle, common atrial chamber, and proximal portion of the horns of
the sinus venosus by embryonic day 10.0 pc (Fig 2B
). By day 12.5 to
13.0 pc, Gax protein expression appeared to peak (Fig 2C
and 2D
). By
day 13.5 pc, Gax protein was undetectable by immunohistochemistry but
again readily detectable by day 15.5 pc in the nuclei of some cells
within the compact layer of the ventricle (Fig 2E
and 2F
). This
expression pattern within the ventricular myocardium persisted through
day 17.5 pc (data not shown). Gax was not detected at any point during
cardiogenesis in the endocardium or epicardium or in the region of the
endocardial cushions or interatrial septa.
|
The biphasic expression of gax transcripts was also
detected by in situ hybridization (Fig 3A
to 3C). At day
12.5 pc, gax mRNA expression was detected in both the atria
and ventricles, but by day 14 pc, the level of in situ signal had
dropped close to background, whereas a strong signal was still detected
in the lung. By day 15.5 pc, gax mRNA was once again
detectable, limited to the compact layer of the ventricle.
Immunohistochemical analyses, performed with the
-Gax 8.1 or
-Gax
2.1 antibodies without counterstain, revealed appreciable
perinuclear/cytoplasmic staining in separate 8.0- to 8.5-pc embryonic
hearts (Fig 3D
and 3E
). However, prominent nuclear signal was also
detected in cardiomyocytes from day-15.5-pc hearts (Fig 3F
and 3G
). To test whether the same protein was recognized by both antibodies
in the early versus late embryonic cardiomyocytes, Western blot
analyses were performed on day-12-pc hearts, chosen because of relative
tissue abundance and Gax's appreciable cytoplasmic/perinuclear
expression (Fig 2D
) and 15- and 18-day-pc hearts because of the
presence of appreciable nuclear signal at these time points (Fig 3F
and 3G
and data not shown). In embryonic day-12, -15, and -18 hearts, both
antibodies recognized bands of identical electrophoretic mobility,
corresponding to the predicted molecular weight of endogenous
Gax1 (Fig 3H
).
|
Smooth muscle. Gax protein expression was
detected in the embryonic hindgut by day 9.5 pc (Fig 4A
). Protein expression was clearly apparent in two
layers of the stomach by day 12.5 pc, a well-defined inner (submucosal)
and a more diffuse external layer, which extended from the stomach to
the distal intestine (Fig 4B
). By day 15.5 pc, Gax expression appeared
more discretely organized and in later embryos was present in two
clearly distinct layers, the muscularis submucosa and muscularis
externa (Fig 4C
). Gax expression in the submucosa appeared to be
predominantly nuclear, whereas the staining was more diffuse in the
muscularis externa (Fig 4D
). Other sites of visceral smooth muscle that
expressed Gax included the posterior pharynx and esophagus (Figs 2E
and 6F
), the diaphragm (Fig 2E
), and the bladder (data not shown). Gax
expression was present within the mesenchyme surrounding the tubules
and glomeruli in the kidney by day 12.5 pc (data not shown) in a
pattern consistent with mesangial and juxtaglomerular cells, which have
contractile and proliferative properties similar to smooth muscle
cells. Gax protein expression was also detected within the lung and was
restricted to the mesodermally derived mesenchyme (data not shown),
which expresses smooth muscle markers.26 At no point
during development was Gax detectable within the endodermally derived
bronchi or respiratory epithelium of the lung. Expression of Gax was
detected in the embryonic vasculature of several organs including
thymus (Fig 2E
) and kidney (data not shown). With the exception of
umbilical vessels, Gax was not readily detectable in larger blood
vessels at early developmental time points but was detectable within
the maternal component of the decidua (data not shown). Of note, Gax
protein has been detected in the smooth muscle of adult human aorta,
vasa vasorum, saphenous veins, and internal mammary arteries (H.A.
Skopicki and K. Walsh, unpublished data, 1996).
|
|
Gax Expression in Somites and Skeletal Muscle
Gax protein was detected in the first somites around day 8.0 pc,
and this signal intensified with mesodermal condensation (Fig 5A
and 5B
). During somite differentiation, Gax was prominently
and uniformly expressed throughout the dermatomyotome and sclerotome
(Fig 5C
). Gax expression remained high during migration of cells from
somites into the trunk around day 9.0 pc (Fig 5D
). Neither myogenin nor
MyoD protein was present in the migrating myoblasts of adjacent
sections at this time point (data not shown; see also Reference 2727 ).
Gax protein was noted in myoblasts surrounding the early
chondrification centers of ribs and vertebrae (Fig 5E
). Gax expression
was present in lateral somites migrating into the developing limbs as
early as day 9.5 pc (Fig 5F
). By days 12.5 to 15.5 pc, both the
forelimbs and hindlimbs displayed expression at the periphery of the
limb buds and in developing muscle masses (Fig 6A
to
6C). Gax protein in the branchial arches was apparent by
day 9.5 pc (data not shown), and several head and neck muscles,
including the tongue, jaw, and extraocular muscles, had clear evidence
of Gax expression by days 10.5 to 15.5 pc (Fig 6D
and 6G
). High levels
of Gax protein were also noted in the region surrounding, but not
within, whisker follicles (Fig 6D
, 6E
, and 6G
).
|
Neurectodermal Derivatives Express Gax
As with most homeobox genes, a neuroectodermal distribution of Gax
protein was detected. Expression of Gax in the central nervous system
was noted by day 8.0 pc (Figs 2A
and 5A
), extending from the ventricles
of the developing brain to the neural tube (in the ventricular zone of
the brain and ependymal [proliferating] and mantle layers of the
neural tube) (data not shown). Derivatives of the neural tube
expressing Gax included the retina (Fig 6G
) and olfactory epithelium
(Fig 6E
), and neural crest derivatives that express Gax included the
cranial ganglia, adrenal medulla, and dorsal root ganglia (data not
shown).
Localization of Gax Gene Transcripts
In situ hybridization was used to examine whether
gax mRNA could be detected in the same tissues as the
protein. Fig 7
presents a summary of the in situ
hybridization results. Fig 7A
shows gax expression in
differentiating somites. Gax was detected in more cells than
the myotome, which was labeled by a probe for MyoD (Fig 7A
and 7B
). Fig 7C
demonstrates gax expression in developing limbs, and Fig 7D
demonstrates gax expression both in skeletal muscle cells
in the developing myotomes and in the differentiating visceral smooth
muscle of the stomach. The level of background grains in these
experiments was very low (Fig 7E
). Fig 7F
shows gax
expression in skeletal muscles at 15.5 days pc. Fig 7G
demonstrates
gax expression in the branchial arches and neural tube
caudal to the regions seen in Fig 7A
and 7B
. Fig 7H
shows
gax expression in lung mesenchyme. Fig 7H
also shows
gax expression in intercostal muscle, in the diaphragm, and
around cartilage. Fig 7I
shows gax expression in tongue, in
nasal sinus epithelium, and around the oral cavity. Gax gene
transcripts were also detected surrounding the inner ear (Fig 7I
).
| Discussion |
|---|
|
|
|---|
Gax in Cardiac Muscle Development
Gax expression in the developing heart was detected in
cardiomyocytes but not in endocardial or pericardial structures.
Moreover, Gax was not present in cells contributing to the endocardial
cushions or the outflow tracts. Gax expression in cardiomyocytes was
biphasic. Gax protein was detected very early in cardiac development,
being clearly evident by day 8.0 pc in the heart tubes, and its
expression appeared to intensify in both atrial and ventricular
myocytes past day 12.5 pc. However, by day 13.5 pc, the levels of Gax
protein were below the limit of immunohistochemical detection. This
drop in Gax protein expression correlated with a decrease in
gax mRNA expression. By day 15.5 pc, Gax protein and mRNA
were again detectable but limited to cells within the compact layer of
the ventricle.
Appreciable perinuclear/cytoplasmic Gax signal was detected with either of two antibodies in early embryonic cardiomyocytes. In addition to early cardiomyocytes, notable cytoplasmic/perinuclear expression was also apparent in neuroblasts, cells of the adrenal medulla, and some visceral smooth muscle. Thus, it is tempting to speculate that Gax may accumulate in the cytoplasm (in response to a nuclear exclusion mechanism) in anticipation of precise developmental time points when it will be required for transcriptional regulation within the nucleus. A similar regulatory mechanism has been proposed for the Drosophila homeodomain protein Extradenticle.29 Alternatively, Gax may have regulatory functions within the cytoplasm, as has been recently described for the bicoid homeoprotein, which inhibits caudal translation by binding, via its homeodomain, to a site in the 3' untranslated region of the caudal transcript.30 31 A number of other transcription factors, including MyoD and SRF, are also regulated at the level of import into the nucleus.32 33
Gax in Smooth Muscle Differentiation
The embryonic origins of smooth muscle are less well defined than
those for striated muscle. A population of vascular smooth muscle cells
is derived from neural crest, but other vascular smooth muscle cells
have an origin independent of neural crest.14 15 Visceral
smooth muscle cells arise from the lateral plate mesoderm and from
local mesenchyme within developing organs, apparently through inductive
processes.13 It has been difficult to identify smooth
muscle cells during embryonic development because of a lack of specific
markers. Smooth muscle myosin heavy chain appears to be a marker for
these cells in the mouse embryo.34
Our observations suggest that Gax may be an early marker for visceral
smooth muscle differentiation. We detected Gax protein in the gut
primordium by day 9.5 pc, which is 3 days before the detection of
smooth muscle myosin heavy chain mRNA.34
SM22
mRNA, although present at day 9.5 pc in the vascular
smooth muscle, is not expressed in visceral smooth muscle until 13.5
pc.35 Like Gax, SM22
is also expressed in cardiac and
skeletal muscle during development. The expression of Gax in the
developing gut is also similar to that of Nkx-2.5/Csx and
other homeobox genes.8 36 37 38 Although the null mutation of
Nkx-2.5 shows no gastrointestinal abnormalities (perhaps
because embryos are not sufficiently developed when they die in utero),
disruption of the Drosophila homeobox gene
tinman, a homologue of Nkx-2.5, results in the
absence of visceral smooth muscle of the midgut.6 39 The
expression of Gax in the renal and pulmonary stroma is consistent with
the detection of Gax in cells of the smooth muscle lineage. As has been
noted by several investigators, the renal cortex contains contractile
cells (juxtaglomerular and mesangial cells) that are similar in
phenotype to smooth muscle.40 In fact, gax mRNA
expression has previously been detected in adult mesangial cell
culture.1 Moreover, muscle cell markers such as
-actin
and smooth muscle myosin have been described in the developing lung,
where Gax is also expressed.26 41
Gax in Somites and Skeletal Muscle
Gax protein expression occurs with the earliest somite formation,
and its expression persists as the somites differentiate into
sclerotome and premyogenic cells migrate to form both body wall and
limb myoblasts.42 43 Gax protein expression is present in
somites before the expression of the first myogenic bHLH
proteins.44 Gax is also detected before the appearance of
the mef2 family mRNAs.10 At later stages of
skeletal muscle development, Gax is detected predominantly at the ends
of developing muscle fibers, a localization that has been noted for
mef2C45 and mef2B11
transcripts.
Gax expression in presumptive migrating myoblasts is similar to that of Pax-3, a mouse paired homeobox gene that labels the migratory cells of the dermatomyotome and developing limb buds.46 47 Splotch mice, which express a mutated Pax-3 gene, lack limb musculature. Gax expression in limb buds appears first proximally and then along the periphery of the limb, avoiding the apical ectodermal ridge. This is coincident with the migration pattern of committed myoblasts, which also follows a proximal to peripheral pattern and is unlike other homeobox genes, such as the Hox 4 genes, which are more concentrated distally and posteriorly, and undergo sequential activation at the limb's tip as it continues to grow.48 Finally, Gax is also expressed in all skeletal muscles of the face, jaw, and neck.
Gax and MEF2
At a molecular level, the conserved features of cardiac,
smooth, and skeletal muscle developmental programs are poorly
understood. The MEF2 transcription factors represent one component of
the regulatory mechanism controlling gene expression in each of these
cell lineages (for review, see Reference 4949 ). The identification of Gax
in all three muscle types suggests that it may also participate in this
common regulatory pathway during growth arrest and differentiation.
Interestingly, Gax overlaps in its expression pattern with
mef2 transcripts, particularly mef2B and
mef2C, known regulators of gene transcription in all three
muscle types.10 11 50 Similar to Gax protein expression,
expression of mef2C mRNAs becomes evident in the precardiac
mesoderm beginning at day 7.5 pc, returning to near background levels
by day 13.5.10 The somitic expression of mef2
transcripts is similar to that of Gax, but mef2 transcripts
are limited to the myotome. Interestingly, Gax and MEF2 are expressed
in cells of neuronal lineage, which suggests that they may also have a
role in neuron differentiation.51 The overlapping patterns
of mef2 and Gax expression and the direct regulation of
gax gene transcription by MEF2 noted
previously18 indicate that MEF2 may participate in the
regulation of Gax expression during embryogenesis. These data also
suggest that the Gax homeoprotein may mediate some of the developmental
functions of the MEF2 transcription factors.
In summary, these data demonstrate that Gax is expressed in all three muscle lineages. Gax protein expression occurs early in cardiogenesis with detection in the heart tube several days before cardiac looping. In addition, Gax is among the earliest proteins expressed in smooth muscle cells, appearing in the gut by embryologic day 9.5 pc. In the skeletal muscle lineage, Gax protein expression in somites occurs early, before the appearance of the myogenic bHLH proteins, and Gax is also expressed in migrating myoblasts and in mature skeletal muscle in all regions of the embryo. On the basis of its structure as a homeodomain protein, its early embryonic expression pattern, and its expression in muscle that coincides with the MEF2 transcription factors, Gax may play an important role in the differentiation pathway in myocytes of all three muscle lineages.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received May 16, 1996; accepted December 18, 1996.
| References |
|---|
|
|
|---|
2. Weir L, Chen D, Pastore C, Isner JM, Walsh K. Expression of GAX, a growth-arrest homeobox gene, is rapidly down-regulated in the rat carotid artery during the proliferative response to balloon injury. J Biol Chem. 1995;270:5457-5461.
3. Zhan Q, et al. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol. 1994;14:2361-2371.
4. Manifioletti G, Ruaro ME, Del Sal G, Philipson L, Schneider C. A growth arrest-specific (gas) gene codes for a membrane protein. Mol Cell Biol. 1990;10:2924-2930.
5. LePage DF, Altomare DA, Testa JR, Walsh K. Molecular cloning and localization of the human GAX gene to 7p21. Genomics. 1994;24:535-540.
6. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L, Harvey RP. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeobox gene Nkx2-5. Genes Dev. 1995;9:1654-1656.
7. Komuro I, Izumo S. Csx: a murine homeobox-containing gene specifically expressed in the developing heart. Proc Natl Acad Sci U S A. 1993;90:8145-8149.
8. Lints TJ, Parsons LM, Hartley L, Lyons I, Harvey RP. NKX-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development. 1993;119:419-431.
9. Heikinheimo M, Scandrett JM, Wilson DB. Localization of transcription factor GATA-4 to regions of the mouse embryo involved in cardiac development. Dev Biol. 1994;164:361-373.
10. Edmondson DG, Lyons GE, Martin JF, Olson EN. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development. 1994;120:1251-1263.
11. Molkentin JD, Firulli AB, Black BL, Martin JF, Hustad CM, Copeland N, Jenkins N, Lyons G, Olson EN. MEF2B is a potent transactivator expressed in early myogenic lineages. Mol Cell Biol. 1996;16:3814-3824.
12. Srivastava D, Cserjesi P, Olson EN. A subclass of bHLH proteins required for cardiac morphogenesis. Science. 1995;270:1995-1999.
13. Cunha GR, Battle E, Young P, Brody JR, Donjacour A, Hayashi N, Kinbara H. Role of epithelial-mesenchymal interactions in differentiation and spatial organization of visceral smooth muscle. Epithelial Cell Biol. 1992;1:76-83.
14. Hood LC, Rosenquist TH. Coronary artery development in the chick: origin and deployment of smooth muscle cells and the effects of neural crest ablation. Anat Rec. 1992;234:291-300.
15. Kirby ML. Cellular and molecular contributions of the cardiac neural crest to cardiovascular development. Trends Cardiovasc Med. 1993;3:18-23.
16. Suzuki E, Guo K, Kolman M, Yu Y-T, Walsh K. Serum-induction of MEF2/RSRF expression in vascular myocytes is mediated at the level of translation. Mol Cell Biol. 1995;15:3415-3423.
17. Firulli AB, Miano JM, Bi W, Johnson AD, Casscells W, Olson EN, Schwarz JJ. Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells. Circ Res. 1996;78:196-204.
18. Andrés V, Fisher S, Wearsch P, Walsh K. Regulation of Gax homeobox gene transcription by a combination of positive factors including MEF2. Mol Cell Biol. 1995;15:4272-4281.
19. Wachtler F, Christ B. The basic embryology of skeletal muscle formation in vertebrates: the avian model. Dev Biol. 1992;3:217-227.
20. Olson EN, Klein WH. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 1994;8:1-8.
21.
Schatteman GC, Morrison-Graham K, Van Koppen A, Weston
JA, Bowen-Pope DF. Regulation and role of PDGF receptor
-subunit expression and during embryogenesis.
Development. 1992;115:1749-1759.
22. Schatteman GC, Lunger T, Lanahan AA, Bothwell MA. Distribution of the 75-kD low-affinity nerve growth factor receptor in the primate peripheral nervous system. Somatosens Mot Res. 1993;10:415-432.
23. Lyons GE, Ontell M, Cox R, Sassoon D, Buckingham M. The expression of myosin genes in developing skeletal muscle in the mouse embryo. J Cell Biol. 1990;111:1465-1476.
24. Sassoon D, Lyons G, Wright W, Lin V, Lassar A, Weintraub H, Buckingham M. Expression of two myogenic regulatory factors: myogenin and MyoD1 during mouse embryogenesis. Nature. 1989;341:303-307.
25. Tanaka M, Herr W. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell. 1990;60:375-386.
26. Mitchell JJ, Reynolds SE, Leslie KO, Low RB, Woodcock MJ. Smooth muscle cell markers in developing rat lung. Am J Respir Cell Mol Biol. 1990;3:515-523.
27. Cusella-De Angelis MG, Lyons G, Sonnino C, De Angelis L, Vivarelli E, Farmer K, Wright WE, Molinaro M, Bouche M, Buckinghman M, Cossu G. MyoD, myogenin independent differentiation of primordial myoblasts in mouse somites. J Cell Biol. 1992;116:1243-1255.
28. Candia AF, Hu J, Crosby JL, Lalley PA, Noden D, Nadeau JH, Wright CV. Mox-1 and Mox-2 define a novel homeobox gene subfamily, and are differentially expressed during early mesodermal patterning in mouse embryos. Development. 1992;116:1123-1136.
29. Mann RS, Abu-Shaar M. Nuclear import of the homeodomain protein Extradenticle in response to Wg and Dpp signalling. Nature. 1996;383:630-633.
30. Dubnau J, Struhl G. RNA recognition and translational regulation by a homeodomain protein. Nature. 1996;379:694-699.
31. Rivera-Pomar R, Niessing D, Schmidt-Ott U, Gehring WJ, Jackle H. RNA binding and translational suppression by bicoid. Nature. 1996;379:746-749.
32. Vandromme M, Gauthier-Rouvière C, Lamb N, Fernandez A. Regulation of transcription factor localization: fine-tuning of gene expression. Trends Biochem Sci. 1996;21:59-64.
33. Chen C-MA, Kraut N, Groudine M, Weintraub H. I-mf, a novel myogenic repressor, interacts with members of the MyoD family. Cell. 1996;86:731-741.
34. Miano JM, Cserjesi P, Ligon KL, Periasamy M, Olson EN. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res. 1994;75:803-812.
35.
Li L, Miano JM, Cserjesi P, Olson EN. SM22
, a
marker of adult smooth muscle, is expressed in multiple myogenic
lineages during embryogenesis. Circ Res. 1996;78:188-195.
36. Lints TJ, Hartley L, Parsons LM, Hartley RP. Mesoderm-specific expression of the divergent homeobox gene Hlx during murine embryogenesis. Dev Dynam. 1996;205:457-470.
37. Galliot B, Dolle P, Vigneron M, Featherstone MS, Baron A, Duboules D. The mouse Hox-1.4 gene: primary structure, evidence for promoter activity and expression during development. Development. 1989;107:343-359.
38. Suh E, Chen L, Taylor J, Traber PG. A homeodomain protein related to caudal regulates intestine-specific gene transcription. Mol Cell Biol. 1994;14:7340-7351.
39. Bodmer R. The gene tinman is required for specification of the heart and visceral muscles in Drosophila. Development. 1993;118:719-729.
40. Mené P, Simonson MS, Dunn MJ. Physiology of the mesangial cell. Physiol Rev. 1989;69:1347-1424.
41. Leslie KO, Mitchell JJ, Woodcock MJ, Low RB. Alpha smooth muscle actin expression in developing and adult human lung. Differentiation. 1990;44:143-149.
42. Ordahl CP, LeDouarin NM. Two myogenic lineages within the developing somite. Development. 1992;114:339-353.
43. Tam PPL, Beddington RS. The formation of mesodermal tissues in the mouse embryo during gastrulation and early organogenesis. Development. 1987;99:109-126.
44. Smith TH, Kachinsky AM, Miller JB. Somite subdomains, muscle cell origins, and the four muscle regulatory factor proteins. J Cell Biol. 1994;127:95-105.
45. Lyons GE, Micales BK, Kim S, Herr M, Swanson BJ. In situ analysis of muscle gene expression in mouse embryos. J Anim Sci. 1996;74:(Suppl 2):1-8.
46. Bober E, Franz T, Arnold H, Gruss P, Tremblay P. Pax-3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle cell progenitors. Development. 1994;120:603-612.
47. Williams BA, Ordahl CP. Pax-3 expression in segmental mesoderm marks early stages in myogenic cell specification. Development. 1994;120:785-796.
48. Izpisúa-Belmonte JC, Tielde C, Dollé P, Wolpert L, Duboule D. Expression of the homeobox Hox-4 genes and the specification of position in chick wing development. Nature. 1991;350:585-589.
49. Olson EN, Perry M, Schulz RA. Regulation of muscle differen-tiation by the MEF2 family of MADS box transcription factors. Dev Biol. 1995;172:2-14.
50. Martin JF, Schwarz JJ, Olson EN. Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc Natl Acad Sci U S A. 1993;90:5282-5286.
51. Lyons GE, Micales BK, Schwarz J, Martin JF, Olson EN. Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J Neurosci. 1995;15:5727-5738.
This article has been cited by other articles:
![]() |
P. Liu, C. Zhang, J. B. Feng, Y. X. Zhao, X. P. Wang, J. M. Yang, M. X. Zhang, X. L. Wang, and Y. Zhang Cross Talk Among Smad, MAPK, and Integrin Signaling Pathways Enhances Adventitial Fibroblast Functions Activated by Transforming Growth Factor-{beta}1 and Inhibited by Gax Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 725 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen and D. H. Gorski Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5 Blood, February 1, 2008; 111(3): 1217 - 1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, A. D. Leal, S. Patel, and D. H. Gorski The Homeobox Gene GAX Activates p21WAF1/CIP1 Expression in Vascular Endothelial Cells through Direct Interaction with Upstream AT-rich Sequences J. Biol. Chem., January 5, 2007; 282(1): 507 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Gianakopoulos and I. S. Skerjanc Hedgehog Signaling Induces Cardiomyogenesis in P19 Cells J. Biol. Chem., June 3, 2005; 280(22): 21022 - 21028. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Patel, A. D. Leal, and D. H. Gorski The Homeobox Gene Gax Inhibits Angiogenesis through Inhibition of Nuclear Factor-{kappa}B-Dependent Endothelial Cell Gene Expression Cancer Res., February 15, 2005; 65(4): 1414 - 1424. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Gorski and K. Walsh The Role of Homeobox Genes in Vascular Remodeling and Angiogenesis Circ. Res., November 10, 2000; 87(10): 865 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O Hiltunen, M. P Turunen, M. Laitinen, and S. Yla-Herttuala Insights into the molecular pathogenesis of atherosclerosis and therapeutic strategies using gene transfer Vascular Medicine, February 1, 2000; 5(1): 41 - 48. [Abstract] [PDF] |
||||
![]() |
P. Sridhar, Y. Liu, L. D. Chin, C. E. Borja, M. Mann, H. A. Skopicki, and R. R. Freter Platelet-Derived Growth Factor-Stimulated Expression of the MCP-1 Immediate-Early Gene Involves an Inhibitory Multiprotein Complex Mol. Cell. Biol., June 1, 1999; 19(6): 4219 - 4230. [Abstract] [Full Text] [PDF] |
||||
![]() |
R C Smith, D Branellec, D H Gorski, K Guo, H Perlman, J F Dedieu, C Pastore, A Mahfoudi, P Denefle, J M Isner, et al. p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes & Dev., July 1, 1997; 11(13): 1674 - 1689. [Abstract] [PDF] |
||||
![]() |
S. Fisher, E Siwik, D Branellec, K Walsh, and M Watanabe Forced expression of the homeodomain protein Gax inhibits cardiomyocyte proliferation and perturbs heart morphogenesis Development, January 11, 1997; 124(21): 4405 - 4413. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |